Galmed Pharmaceuticals Ltd
(NASDAQ:GLMD)
$0.398
0.003[0.76%]
Last update: 8:34AM (Delayed 15-Minutes)
Get Real Time Here
$0.398
0[0.00%]
After-Hours
Open-Close-
Vol / Avg.0 / 177.472KMkt Cap1.595M
Day Range- - -52 Wk Range0.260 - 14.175

Galmed Pharmaceuticals Stock (NASDAQ:GLMD), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.

Consensus Rating1

Buy

Highest Price Target1

$4.00

Lowest Price Target1

$1.00

Consensus Price Target1

$7.17

Analyst Rating Summary1

BuyOverweightHoldUnderweightSell
30200

Analyst Firms Making Recommendations1

  • Maxim Group
  • Canaccord Genuity
  • Raymond James
  • HC Wainwright & Co.

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Galmed Pharmaceuticals

Upgrades (1)

Downgrades (4)

Initiations (0)

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
07/24/2023GLMDBuy Now
Galmed Pharmaceuticals
$0.40905.03%Maxim Group
Jason McCarthy
→ $4UpgradeHold → BuyGet Alert
08/08/2022GLMDBuy Now
Galmed Pharmaceuticals
$0.40Maxim Group
Jason McCarthy
DowngradeBuy → HoldGet Alert
08/08/2022GLMDBuy Now
Galmed Pharmaceuticals
$0.40151.26%Canaccord Genuity
Edward Nash
$75 → $15DowngradeBuy → HoldGet Alert
05/18/2022GLMDBuy Now
Galmed Pharmaceuticals
$0.40Raymond James
Steven Seedhouse
DowngradeOutperform → Market PerformGet Alert
05/03/2022GLMDBuy Now
Galmed Pharmaceuticals
$0.40HC Wainwright & Co.
Ed Arce
DowngradeBuy → NeutralGet Alert
05/03/2022GLMDBuy Now
Galmed Pharmaceuticals
$0.401156.28%Raymond James
Steven Seedhouse
$210 → $75MaintainsOutperformGet Alert
05/17/2021GLMDBuy Now
Galmed Pharmaceuticals
$0.405176.38%Canaccord GenuityMaintainsBuyGet Alert
03/19/2021GLMDBuy Now
Galmed Pharmaceuticals
$0.406181.41%HC Wainwright & Co.
Ed Arce
MaintainsBuyGet Alert
01/08/2021GLMDBuy Now
Galmed Pharmaceuticals
$0.404171.36%Raymond JamesMaintainsOutperformGet Alert
Q

What is the target price for Galmed Pharmaceuticals (GLMD)?

A

The latest price target for Galmed Pharmaceuticals (NASDAQ: GLMD) was reported by Maxim Group on July 24, 2023. The analyst firm set a price target for $4.00 expecting GLMD to rise to within 12 months (a possible 905.03% upside). 1 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Galmed Pharmaceuticals (GLMD)?

A

The latest analyst rating for Galmed Pharmaceuticals (NASDAQ: GLMD) was provided by Maxim Group, and Galmed Pharmaceuticals upgraded their buy rating.

Q

When is the next analyst rating going to be posted or updated for Galmed Pharmaceuticals (GLMD)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Galmed Pharmaceuticals, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Galmed Pharmaceuticals was filed on July 24, 2023 so you should expect the next rating to be made available sometime around July 24, 2024.

Q

Is the Analyst Rating Galmed Pharmaceuticals (GLMD) correct?

A

While ratings are subjective and will change, the latest Galmed Pharmaceuticals (GLMD) rating was a upgraded with a price target of $0.00 to $4.00. The current price Galmed Pharmaceuticals (GLMD) is trading at is $0.40, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.